ICON plc, a clinical research organization, expanded its portfolio of artificial intelligence (AI) tools that aim to deliver efficiencies across the clinical trial process, including study startup, ...
The amendment comprises additional changes to reflect the execution of the operating license and indemnity agreement (“ OLIA ”) with Glencore in January 2024, including that the funding of the second ...
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced ...
First Helium Inc. (“First Helium” or the “Company”) (TSXV: HELI) (OTCQB: FHELF) (FRA: 2MC) today announced that it has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback